Sinovac Biotech Ltd. (SVA)
Market Open
11 Feb, 05:18
NASDAQ (NGS) NASDAQ (NGS) Primary $
6. 47
0
0%
$
464.94M Market Cap
- P/E Ratio
- Div Yield
0 Volume
- Eps
$ 6.47
Previous Close Want to track SVA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Sinovac Biotech Ltd. (SVA) Statistics
Valuation metrics
Market Cap 464.94M
Enterprise value -506.21M
Trailing P/E (ttm) -6.45
Forward P/E -
PEG ratio -0.06
Price/Sales (ttm) 1.04
Price/Book (mrq) 0.07
Enterprise Value/Revenue -1.13
Enterprise Value/EBITDA 83.96
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 6.47
52-Week high 6.47
Beta -
50-Day moving average 6.47
200-Day moving average 6.47
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -0.22%
Operating margin -1.22%
Operational effectiveness
Return on assets -0.01%
Return on equity -0.01%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 4.5
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 112.67
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 10.31%
Book value per share (mrq) 120.7
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
